Akari Therapeutics
Akari Therapeutics is an innovative targeted oncology company developing next‑generation antibody‑drug conjugates (ADCs) and a novel discovery engine. The firm focuses on advancing ADC payloads with novel immuno‑oncology payloads, expanding its intellectual property portfolio, and presenting corporate information through its investor and corporate sites.
Akari Therapeutics is listed with 1 API on the APIs.io network. Tagged areas include Company, Oncology, ADC, Biotechnology, and Therapeutics.
Akari Therapeutics’ developer surface includes documentation, getting-started guide, and 7 more developer resources.
Kin Score
APIs 1
Individual APIs this provider publishes, each with its own machine-readable definition.
Akari Therapeutics API
API reference not publicly documented; no machine‑readable contract discovered.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 2
Portal, sign-up, and the first successful call
Documentation 1
Reference material describing how the API behaves
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API
Other 2
Properties that don't map to a standard resource type
Source (apis.yml)
Akari Therapeutics API — frequently asked questions
Does Akari Therapeutics have an API?
Yes. APIs.io lists 1 API from Akari Therapeutics, including Akari Therapeutics API.
Is the Akari Therapeutics API ready for AI agents?
Akari Therapeutics has a Kin Score of 15.8 out of 100 (emerging) and an Agent Readiness score of 0.0 (human-only), scored by API Evangelist on 2026-10-31.
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.